Skip to main content
Clinical Trials/NCT06439823
NCT06439823RecruitingNot Applicable

Controlled Study of Upper and Lower Limb Movements in Patients Patients with Pathologies That Have an Impact on Ambulation or Motor Function to Validate Signal Analysis Algorithms for Wearable Devices Using Magneto-inertial Technology

Laurent Servais1 site in 1 country200 target enrollmentStarted: August 24, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
step length and distance

Study Overview

Brief Summary

The main aim of the study is to validate the algorithms developed to analyze the signals from the various sensors contained in the magneto-inertial control units and reconstruct upper and lower limb movements under different normal and pathological conditions.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
2 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Subjects over 2 years old
  • •Male or female
  • •Control subjects with no pathologies that have an impact on ambulation or motor function.
  • •Signed informed consent and, in the case of minors, informed consent signed by the person with parental authority/guardian

Exclusion Criteria

  • •Any other previous or present pathology having an impact on current motor or balance function
  • •Recent surgery or trauma to upper or lower limbs, or major surgery or trauma within 6 months of inclusion.
  • •For control subjects, athlete of at least national level.
  • •Pregnant or breast-feeding women

Arms & Interventions

Patient with neuromuscular disease or control subjects

Experimental

Patients and controls will be examined by a neuropediatric or neurologist. they will perform upper and lower limb assessments in a walking laboratory. this study comprises a single session per patient/control subject.

Intervention: ActiMyo®/Syde® (Device)

Outcomes

Primary Outcomes

step length and distance

Time Frame: 36 months

Validate the algorithms developed to analyze the signals from the various sensors contained in magneto-inertial control units and reconstruct upper and lower limb movements.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Laurent Servais
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Laurent Servais

Professor Laurent Servais

Centre Hospitalier Universitaire de Liege

Study Sites (1)

Loading locations...

Similar Trials